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ABSTRACT
The prognosis for patients with ventricular arrhythmias has improved dramatically with the aid of
implantable cardioverter-defibrillators (ICDs). Although infection is a serious complication that frequently
causes dysfunction and loss of ICDs, the frequency, predisposing risk-factors, and clinical and
microbiological features are only partially understood. This study describes a retrospective review of
423 procedures in 278 patients with ICD primary implants and replacements performed at a tertiary-care
hospital. Generators were placed in either a pectoral (68%) or abdominal (32%) site, and electrodes were
placed transvenously in 97% of the patients. Most (95%) interventions were performed in a one-stage
procedure. Infection developed with ten (2.4%) implanted devices. Four cases occurred within 30 days of
surgery (‘early infections’) and six occurred > 1 month after surgery (‘late infections’). In univariate
analysis, factors associated with the development of an early infection were: two-stage surgery, a sub-costal
approach, and abdominal generator placement. In patients with late infections, a significant association
was found with trauma or decubitus ulcer in the generator area. Infection presented with local signs
without systemic complications. Seven of the ten patients required complete removal of the system.
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INTRODUCTION
The use of implantable cardioverter-defibrillators
(ICDs) has changed dramatically the prognosis
for patients with life-threatening ventricular
arrhythmias [1–3]. Improvements in surgical tech-
niques and device design have contributed to gains
in effectiveness and safety [4–6], and the use of
ICDs has increased significantly during the last two
decades [7,8]. Infection is an uncommon, but
serious, complication of ICD implantation.
Although still controversial, risk-factors associated
with infection include two-stage surgery, place-
ment of the device through a median sternotomy or
thoracotomy, abdominally placed generators and
battery replacement, as well as diabetes mellitus,
advanced age, depressed immunity and primary
bacteraemia [5–13]. Management of infection often
requires complete removal of the system.
The purpose of the present study was to
determine the frequency of ICD infection in a
large cohort of patients in a single university
hospital, and to assess the risk-factors, clinical
presentation, management and outcome of
patients with infected ICD systems.
PATIENTS AND METHODS
A retrospective review of the hospital charts of patients
undergoing ICD generator implantation at a university-affili-
ated hospital in Madrid between February 1988 and December
2001 provided data for 278 patients who underwent 423
procedures (262 primary implants, 161 replacements). Patients
had regular follow-up visits every 3–6 months, which included
physical examination and checking of the ICD system. Infec-
tion was diagnosed by the attending physician if fever
(> 37.8C) or any sign of infection (warmth, erythaema,
tenderness or purulent drainage) were observed around the
ICD pocket or surgical wound. Infection was classified on the
basis of the time of presentation as ‘early infection’ (within
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30 days of surgery) or ‘late infection’ (> 1 month following
surgery). Patient data collected included gender, age, New
York Heart Association (NYHA) functional status and systolic
ejection fraction (measured by echocardiography, ventriculog-
raphy, or both), underlying cardiopathy, predisposing factors
for infection (neoplasia, diabetes mellitus, obesity, haemody-
alisis and hypoalbuminaemia < 3 g ⁄dL), anticoagulation
drugs, corticosteroid therapy and the presence of an acute
infectious disease (defined as any infection different from the
ICD infection that developed during the 4-week period
preceding the implant). The length of hospitalisation and the
need for electrophysiological study before implantation (and
the time that elapsed between that procedure and the implant)
were also reviewed.
Antimicrobial prophylaxis comprised either (A) penicillin
plus gentamicin plus cloxacillin, (B) vancomycin for penicillin-
allergic patients, or (C) cefalozin alone, with the precise
regimen being determined by the responsible surgeon. All
prophylactic regimens were administered intravenously from
1 h before surgery until 48 h afterwards.
ICD implants were performed in the operating room by a
cardiovascular surgeon, with the surgery involving either
(i) sternotomy or thoracotomy, followed by placement of
epicardial electrodes with or without patch electrodes (between
1988 and 1991), or (ii) a transvenous procedure, with either a
sub-costal or sub-clavicular approach (from 1991 onwards).
Transvenous electrodes were introduced into the venous
system by transcutaneous cannulation of the left sub-clavian
vein or, if not possible, by the left cephalic vein, jugular vein or
right sub-clavian vein. Electrodes were inserted into the right
ventricular apex. Pulse generators were placed in the abdom-
inal (sub-rectal) or thoracic wall (sub-pectoral or sub-cuta-
neous), tunnelling leads until the correct position was reached.
Statistical analysis
Statistical analysis was based on the total number of proce-
dures. Data were expressed as percentages, means ± standard
deviation (SD) and median ± interquartile range (IQR).
Quantitative variables were analysed by the Kolmogorov-
Smirnoff test to confirm normality of data. When normality
was not shown, logarithmic transformation was performed.
An unpaired Student’s t-test was used to compare the
differences in continuous variables, and the chi-square test
(or Fisher’s exact test, for variables having expected frequen-
cies of £ 5) was used to compare the distribution of discrete
variables. The results were analysed using SPSS v.9.0 software
(SPSS Inc, Chicago, IL, USA). Statistical significance was set at
p < 0.05.
RESULTS
Patients and procedures
In total, 423 procedures performed in 278 patients
were reviewed (262 primary implants and 161
replacements). The main reason for replace-
ment was to renew the battery. Patients were
mainly male (85.6%), and had a mean age of
60 ± 13 years. NYHA functional classifications
were: grade I (62%); grade II (33%); and grade
III (5%). The mean systolic ejection fraction was
35 ± 14% (range 10–86). Ischaemic heart disease
was the most prevalent underlying cardiopathy
(63%), followed by idiopathic dilated myocardio-
pathy (45%), congestive heart failure (22.7%),
atrial fibrillation (20.3%) and valvulopathy
(18.4%). Eleven (3.9%) patients had metallic
valvular prostheses.
Fifty-eight (13.7%) patients were diabetic, 25
(5.4%) had neoplastic diseases, and 21 (5%) were
morbidly obese. Overall, 26% were receiving
anticoagulant therapy. Only a few patients were
receiving haemodialysis (0.7%), corticosteroid
treatment (0.7%) or had hypoalbuminaemia
(2.4%). Thirty-four (8.1%) patients had suffered
from an acute infection within the 4-week period
preceding the implant, with seven patients having
concomitant bacteraemia.
Patients were hospitalised for a mean of
15 days (IQR, 5–30 days), as no patient was
discharged until therapy was completed. The
mean time that elapsed between the electrophys-
iological study and the surgical procedure was
5 days. Most patients were given prophylactic
regimen A (77%), followed by regimens C (14%)
or B (9%). Most ICDs were positioned transven-
ously. The main surgical approach was sub-
clavicular (62.1%), followed by sub-costal
(32.9%). Major surgery was performed in 21 cases
(sternotomy for 19 patients and thoracotomy for
two patients). Only three implants were per-
formed by sternotomy after 1991, because of the
need for simultaneous heart surgery (coronary
artery bypass grafting (CABG) or ventricular
aneurysm resection).
Vascular access was performed via the sub-
clavian route (71.2%). No vascular access was
required for 27.9% of surgical procedures. There-
fore, the pulse generator was placed in the
pectoral position for 289 (68.3%) patients and
in the abdominal position for 134 (31.7%)
patients. In all but 11 (2.6%) cases, the surgical
procedure was performed in one stage. Finally,
the replacement procedures involved renewal of
the pulse generator in 152 of the 161 replace-
ments; in 33 cases, only the lead system was
changed.
Infection rate
Thirty-eight (13.7%) patients developed fever in
the post-surgical period, and another 16 (5.8%)
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patients developed haematoma within the gener-
ator pocket. Overall, ten (2.4%) of 423 procedures
resulted in ICD infection in eight (2.8%) of 278
patients. One patient, who had five ICD replace-
ments, had three non-consecutive infections.
Infections involved five primary implants and
five generator replacements (p 0.4). Four cases
were early infections, occurring a mean of 14 days
(5–21 days) after surgery, and six cases were late
infections, occurring a mean of 26 months (1.5–
84 months) following the procedure. The most
relevant findings of these cases are shown in
Table 1.
Predisposing risk-factors
Among the clinical variables, no significant
association was found with ICD infection. In
particular, the presence of acute infection or
bacteraemia before the ICD implant did not
correlate with ICD infection. By univariate
analysis, infection was observed more fre-
quently in patients with two-stage surgery than
in patients with one-stage surgery (OR 21.7;
95% CI 4.73–99.48; p < 0.01), in patients with a
sub-costal rather than a sub-clavicular approach
(OR 6.62; 95% CI 1.39–31.458; p < 0.01), and in
patients with an abdominal generator site rather
than a pectoral site (OR 5.03; 95% CI 1.32–19.16;
p < 0.04).
Late infections were observed in three patients
with traumatic injuries (direct trauma or surgical
trauma) on the generator site preceding the
development of infection. In another three pa-
tients, infection developed after ulceration of the
skin and partial extrusion of the pulse generator.
Both trauma (p < 0.001) and decubitus ulcer (OR
138.33; 95% CI 14.36–1332.59; p < 0.001) were
associated with late-onset infections.
Microbial aetiology
Microorganisms were isolated from cultures of
the wound or the pulse generator pocket (eight
cases), purulent collection (two cases), and cul-
ture from the generator (two cases) or the leads
(two cases). Blood cultures, when taken, were
negative in the infected patients. Infection was
monomicrobial in five cases: coagulase negative
staphylococci (n = 3), Staphylococcus aureus
(n = 2), and Streptococcus agalactiae (n = 1). Four
infections were polymicrobial: Escherichia coli,
Klebsiella spp. and other Gram-negative bacilli.
No organisms were isolated from one patient
(Table 1).
Clinical presentation
The main clinical symptoms were swelling and
purulent discharge (five cases), followed by fever
(four cases), erythaema (four cases), pain (four
cases) and ulceration of the skin (three cases). No
association was found between ICD infection and
the presence of post-surgical fever or haematoma.
There were no systemic complications, cases of
endocarditis or deaths.
Management and outcome
Early-onset infections. Three patients were given
antimicrobial therapy with cloxacillin or amoxy-
cillin-clavulanate for 2 weeks with a favourable
outcome; local signs of infection disappeared and
no relapses occurred. One of these patients
underwent heart transplantation, with a good
outcome, 4 months after the episode of infection.
A fourth patient also received antimicrobial
therapy, but relapsed twice; complete explanta-
tion of the system was needed to achieve a cure,
Table 1. Relevant characteristics of patients with ICD infection
Gender
Time to
infection
Generator
site
Implant ⁄
replacement Surgery
Trauma ⁄
decubitus
Surgical
approach Aetiology Treatment Outcome
1 F Early Abdominal Implant x 1 – Transvenous Gram-neg. bacilli Antibiotic Cured
2 M Early Pectoral Implant x 1 – Transvenous – Antibiotic Cured
3 M Early Pectoral Implant x 1 – Transvenous Escherichia coli + Klebsiella spp. Antibiotic Cured
4 M Early Abdominal Implant x 2 – Thoracic CNS Antibiotic Relapsed
5 M Late Abdominal Replacement x 1 Trauma Transvenous Escherichia coli + Klebsiella spp. Ab + Surgery Reimplanted
6 M Late Abdominal Replacement x 1 Trauma Transvenous CNS Ab + Surgery Reimplanted
7 F Late Abdominal Replacement x 1 Decubitus Transvenous Streptococcus agalactiae Ab + Surgery Reimplanted
8 M Late Abdominal Replacement x 1 Decubitus Thoracic CNS Ab + Surgery Reimplanted
9 M Late Abdominal Implant x 2 Trauma Thoracic Staphylococcus aureus Ab + Surgery Loss
10 M Late Abdominal Replacement x 1 Decubitus Transvenous Staphylococcus aureus + Bacillus spp. Ab + Surgery Reimplanted
F, female; M, male; CNS, coagulase-negative staphylococci; Ab, antibiotic.
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in conjunction with a full course of vancomycin
and gentamicin.
Late-onset infections. Six episodes were treated
with prolonged courses of antimicrobial agents,
but complete removal and subsequent replace-
ment of the ICD was eventually required in each
instance. Vancomyin plus gentamicin was the
principal antibiotic regimen. One patient had
three different episodes of infection associated
with decubitus ulcers and trauma during a 10-
year period.
DISCUSSION
The present study has some limitations. First, it
was conducted over an extended period and
multiple surgeons of variable training performed
the ICD implants (i.e., the level of experience may
have influenced the results). Second, the small
number of infections associated with ICD infec-
tion makes the detection of differences among
infected and non-infected patients difficult. How-
ever, despite these limitations, this study contri-
butes to an understanding of the epidemiology
and clinical and microbiological aspects of infec-
tions associated with ICDs.
The low overall infection rate of 2.4% (which
was in the middle of the range of 0.2% to 7.2%
reported previously [5–10]) precluded the find-
ing of significant associations among patients.
Remarkably, patients with diabetes mellitus,
obesity or bacteraemia preceding implantation
did not have a higher risk for infection. How-
ever, as noted previously, two-stage surgery, a
sub-costal surgical approach, and abdominal
generator placement, were all associated with
an increased infection risk. Two-stage surgery
may increase the risk for infection as much as
20-fold, as the surgical wound is not isolated
completely from skin flora and secondary mani-
pulation can occur. Fortunately, two-stage
surgery is now performed rarely. Long sub-
cutaneous tunnelling is needed to connect the
leads with the generator for both the sub-costal
approach and in cases where the generator is
located on the abdominal wall, and therefore
more trauma and manipulation occur [7,12]. In
addition, abdominal generators are more bulky
and heavier, leading to the possibility of erosion
and ulceration of the generator pockets. Sub-
costal implantation has been gradually replaced
since 1995 by the sub-clavicular approach, and is
currently under-used.
In the present series, early infections were seen
in only a few patients with primary implants.
These ICD infections mimicked incidental uncom-
plicated surgical wound infections, were caused
by skin contaminants, and were treated easily
with antimicrobial therapy. Fortunately, these
infections did not result in the loss of the ICD.
In contrast, late infections had some distinctive
features of interest. These infections were associ-
ated with replacements of the system, and all the
patients involved had pulse generators placed in
the abdominal wall. In addition, all cases had a
history of previous trauma or decubitus ulcers at
the generator site. It has been suggested previ-
ously that loss of skin integrity is a risk-factor for
late-onset ICD infection [6,8,14]. All the patients
with late-onset infections needed complete
explantation of the system and the reimplantation
of a new device after a prolonged course of
antimicrobial therapy.
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